昊帆生物：8月27日召开董事会会议

Group 1 - The company Haofan Bio announced the convening of its fourth board meeting on August 27, 2025, to review the 2025 semi-annual report and summary [1] - For the year 2024, Haofan Bio's revenue composition is entirely from the manufacturing of chemical raw materials and chemical products, accounting for 100.0% [1] - As of the report date, Haofan Bio has a market capitalization of 6 billion yuan [1]